About Qdot Probes
Qdot Probes is a Healthcare company based in Pittsburgh (United States) founded in 1998, and was acquired by Invitrogen in October 2005. Quantum Dots Nanotech for molecular fluorescent imaging. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Imaging Systems. Its competitors include SpectraWAVE, Ionpath and Invenio Imaging; 3 of its 3 listed competitors have raised funding.
Company details
Quantum Dot Corporation (QDC, now part of Thermo Fisher) licensed nanocrystal technologies developed at Berkeley Lab by Dr. Paul Alivisatos, Shimon Weiss, and colleagues. Due to their unique light emitting properties, Qdots are superior to dye molecules now in use since they allow the simultaneous, color-coded identification of multiple cell structures. Qdots have potential applications in genotyping, DNA expression analysis, protein expression analysis, DNA sequencing, biological assays, imaging systems, research instrumentation, optical bar-coding of chemical and biological materials, tagging systems, and high-throughput screening. Quantum Dot Corporation was acquired by Invitrogen Corporation (now part of Thermo Fisher) in Oct 2005
- Headquarters Pittsburgh, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website qdots.com
- Social LinkedIn X Facebook
- Acquired by Invitrogen (Oct 2005)
- Latest Funding Round$2M (USD), Grant
Sep 2004
- InvestorsNIST
& 1 more
- Acquired byInvitrogen
(Oct 2005)
Funding Insights of Qdot Probes
- Total Rounds 1
- Last Round Grant β $2M
- First Round $2M
(Sep 2004)
- Investors Count 1
All 1 funding rounds of Qdot Probes with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2004 | $2M | Grant | β | β |
2 investors in total: 2 institutional.
Investors in Qdot Probes
Qdot Probes has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include NIST and Invitrogen.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Standards and measurements are developed by NIST for various industries. | 1901 | nist.gov | United States | |
Provider of scientific instruments, services, and consumables | 1987 | invitrogen.com | Carlsbad, United States |
Investor details for Qdot Probes
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Qdot Probes
3 dated milestones of Qdot Probes across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Qdot Probes is founded.
- Funding First funding round of $2.0M.
- Exit Acquired by Invitrogen.
Competitors of Qdot Probes
Qdot Probes has 3 listed competitors in our database, 3 of them funded. They include SpectraWAVE, Ionpath and Invenio Imaging.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| spectrawave.com | 2012 | Waltham, United States | $79.88M | 36 | Photonic imaging diagnostics for cardiovascular disease treatment are provided. | |
| ionpath.com | 2014 | Menlo Park, United States | $18M | 37 | Multiplexed ion beam imaging platform for tissue biopsies is developed. | |
| invenio-imaging.com | 2012 | Santa Clara, United States | $7.5M | Provider of a tissue imagine software and hardware solution for research diagnosis |
Detailed competitors of Qdot Probes
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Qdot Probes (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Qdot Probes
Qdot Probes was founded in 1998 and raised its 1st funding round 6 years after it was founded.
Qdot Probes is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Quantum Dot Corporation (QDC, now part of Thermo Fisher) licensed nanocrystal technologies developed at Berkeley Lab by Dr. Paul Alivisatos, Shimon Weiss, and colleagues. Due to their unique light emitting properties, Qdots are superior to dye molecules now in use since they allow the simultaneous, color-coded identification of multiple cell structures. Qdots have potential applications in genotyping, DNA expression analysis, protein expression analysis, DNA sequencing, biological assays, imaging systems, research instrumentation, optical bar-coding of chemical and biological materials, tagging systems, and high-throughput screening. Quantum Dot Corporation was acquired by Invitrogen Corporation (now part of Thermo Fisher) in Oct 2005.
Qdot Probes's top competitors include Ionpath, SpectraWAVE and Invenio Imaging.
Qdot Probes has 2 investors. Key investors include NIST, and Invitrogen.
Yes. Qdot Probes was acquired by Invitrogen in October 2005.
